Related references
Note: Only part of the references are listed.MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors
Jayavarshni Ganesan et al.
CIRCULATION (2013)
Mammalian heart renewal by pre-existing cardiomyocytes
Samuel E. Senyo et al.
NATURE (2013)
MicroRNA-34a regulates cardiac ageing and function
Reinier A. Boon et al.
NATURE (2013)
Functional screening identifies miRNAs inducing cardiac regeneration
Ana Eulalio et al.
NATURE (2012)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ahmet Ucar et al.
NATURE COMMUNICATIONS (2012)
A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish
Jason E. Fish et al.
DEVELOPMENT (2011)
The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning
Zhen Zhang et al.
DEVELOPMENTAL BIOLOGY (2011)
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
Norimichi Koitabashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling
Paula A. da Costa Martins et al.
NATURE CELL BIOLOGY (2010)
Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models
Norimichi Koitabashi et al.
CIRCULATION RESEARCH (2009)
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Angelika Bonauer et al.
SCIENCE (2009)
Cardiac Neural Crest Expression of Hand2 Regulates Outflow and Second Heart Field Development
Yuka Morikawa et al.
CIRCULATION RESEARCH (2008)
NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure
Meriem Bourajjaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cooperative Synergy between NFAT and MyoD Regulates Myogenin Expression and Myogenesis
Anne-Sophie Armand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Hand2 determines the noradrenergic phenotype in the mouse sympathetic nervous system
Yuka Morikawa et al.
DEVELOPMENTAL BIOLOGY (2007)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Control of stress-dependent cardiac growth and gene expression by a microRNA
Eva van Rooij et al.
SCIENCE (2007)
Re-employment of developmental transcription factors in adult heart disease
Toru Oka et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2007)
Model systems for the study of heart development and disease - Cardiac neural crest and conotruncal malformations
Mary R. Hutson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2007)
Cardiovascular development and the colonizing cardiac neural crest lineage
Paige Snider et al.
THESCIENTIFICWORLDJOURNAL (2007)
Left ventricular hypertrophy: A shift in paradigm
M. F. L. Meijs et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure
Ralph J. van Oort et al.
CIRCULATION (2006)
The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases
Kunhua Song et al.
CELL (2006)
Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability
T Oka et al.
CIRCULATION RESEARCH (2006)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure
J Wang et al.
CIRCULATION RESEARCH (2005)
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy
M Buitrago et al.
NATURE MEDICINE (2005)
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Y Zhao et al.
NATURE (2005)
Requirement of nuclear factor-κB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo
C Freund et al.
CIRCULATION (2005)
Molecular evolution of a microRNA cluster
A Tanzer et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
A Aries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
NF-κB activation is required for the development of cardiac hypertrophy in vivo
YH Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Upregulation of embryonic transcription factors in right ventricular hypertrophy
H Bär et al.
BASIC RESEARCH IN CARDIOLOGY (2003)
Sizing up the heart: development redux in disease
EN Olson et al.
GENES & DEVELOPMENT (2003)
Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy
E van Rooij et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The basic helix-loop-helix factor, HAND2, functions as a transcriptional activator by binding to E-boxes as a heterodimer
YS Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo
QR Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein
DS Sohal et al.
CIRCULATION RESEARCH (2001)
Expression of the receptor tyrosine kinase gene EphB3 during early stages of chick embryo development
RK Baker et al.
MECHANISMS OF DEVELOPMENT (2001)
Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart -: Cross-talk between cardiac hypertrophic signaling pathways
LJ De Windt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo - An apoptosis-independent model of dilated heart failure
LJ De Windt et al.
CIRCULATION RESEARCH (2000)
Share Paper
